| Analysis | Metabolite Name | Measured Value | Units | Treatment |
|---|---|---|---|---|
| Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 4911 | Peak area | Control |
| Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 6247 | Peak area | DEHP treated |
| Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 6743 | Peak area | Control |
| Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 9504 | Peak area | DEHP treated |
| Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | Peak area | Control | |
| Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | Peak area | DEHP treated |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|